APO Research
Talk to an analyst

APO RESEARCH · REPORT

Indometacin and Furazolidone Suppositories

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Indometacin and Furazolidone Suppositories Industry Growth and Trends Forecast to 2032

27 December 202578 pages

Choose your research edition.

Industry ResearchIndometacin and Furazolidone Suppositories Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Indometacin and Furazolidone Suppositories Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Indometacin and Furazolidone Suppositories Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Indometacin and Furazolidone Suppositories Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Indometacin and Furazolidone Suppositories Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Indometacin and Furazolidone Suppositories market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Indometacin and Furazolidone Suppositories is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Indometacin and Furazolidone Suppositories is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Indometacin and Furazolidone Suppositories is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Indometacin and Furazolidone Suppositories include Cixiang Pharmaceutical Hubei Co., Ltd., Harbin Tianmei Pharmaceutical Co., Ltd., Heilongjiang Fudong Pharmaceutical Co., Ltd. and Shanxi Qianyuan Pharmaceutical Group Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Indometacin and Furazolidone Suppositories market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Indometacin and Furazolidone Suppositories market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Indometacin and Furazolidone Suppositories market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Indometacin and Furazolidone Suppositories.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Indometacin and Furazolidone Suppositories market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Indometacin and Furazolidone Suppositories Market by Company

Cixiang Pharmaceutical Hubei Co., Ltd.

Harbin Tianmei Pharmaceutical Co., Ltd.

Heilongjiang Fudong Pharmaceutical Co., Ltd.

Shanxi Qianyuan Pharmaceutical Group Co., Ltd.

Indometacin and Furazolidone Suppositories Segment by Type

Indomethacin 75mg, Furazolidone 0.1g, Erythritol 5mg

Indomethacin 75mg, Furazolidone 0.1g, Borneol 10mg

Indometacin and Furazolidone Suppositories Segment by Application

Hospital

Clinic

Others

Indometacin and Furazolidone Suppositories Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indometacin and Furazolidone Suppositories market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Indometacin and Furazolidone Suppositories and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indometacin and Furazolidone Suppositories.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Indometacin and Furazolidone Suppositories manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Indometacin and Furazolidone Suppositories in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Indomethacin 75mg, Furazolidone 0.1g, Erythritol 5mg Table 2. Major Company of Indomethacin 75mg, Furazolidone 0.1g, Borneol 10mg Table 3. Global Indometacin and Furazolidone Suppositories Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Indometacin and Furazolidone Suppositories Sales by Type (2021-2026) & (K Units) Table 5. Global Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Type (2021-2026) Table 6. Global Indometacin and Furazolidone Suppositories Sales by Type (2021-2026) & (US$ Million) Table 7. Global Indometacin and Furazolidone Suppositories Sales Market Share in Value by Type (2021-2026) Table 8. Global Indometacin and Furazolidone Suppositories Price by Type (2021-2026) & (US$/Unit) Table 9. Global Indometacin and Furazolidone Suppositories Sales by Type (2027-2032) & (K Units) Table 10. Global Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Type (2027-2032) Table 11. Global Indometacin and Furazolidone Suppositories Sales by Type (2027-2032) & (US$ Million) Table 12. Global Indometacin and Furazolidone Suppositories Sales Market Share in Value by Type (2027-2032) Table 13. Global Indometacin and Furazolidone Suppositories Price by Type (2027-2032) & (US$/Unit) Table 14. North America Indometacin and Furazolidone Suppositories Sales by Type (2021-2026) & (K Units) Table 15. North America Indometacin and Furazolidone Suppositories Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Indometacin and Furazolidone Suppositories Sales by Type (2021-2026) & (K Units) Table 17. Europe Indometacin and Furazolidone Suppositories Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Indometacin and Furazolidone Suppositories Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Indometacin and Furazolidone Suppositories Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Indometacin and Furazolidone Suppositories Sales by Type (2021-2026) & (K Units) Table 21. Latin America Indometacin and Furazolidone Suppositories Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Indometacin and Furazolidone Suppositories Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Indometacin and Furazolidone Suppositories Sales by Type (2021-2026) & (US$ Million) Table 24. Indometacin and Furazolidone Suppositories Industry Trends Table 25. Indometacin and Furazolidone Suppositories Industry Drivers Table 26. Indometacin and Furazolidone Suppositories Industry Opportunities and Challenges Table 27. Indometacin and Furazolidone Suppositories Industry Restraints Table 28. Global Indometacin and Furazolidone Suppositories Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Indometacin and Furazolidone Suppositories Revenue Market Share by Company (2021-2026) Table 30. Global Indometacin and Furazolidone Suppositories Sales by Company (2021-2026) & (K Units) Table 31. Global Indometacin and Furazolidone Suppositories Sales Share by Company (2021-2026) Table 32. Global Indometacin and Furazolidone Suppositories Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Indometacin and Furazolidone Suppositories Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Indometacin and Furazolidone Suppositories Major Company Production Sites and Headquarters Table 35. Global Indometacin and Furazolidone Suppositories Company, Product Type & Application Table 36. Global Indometacin and Furazolidone Suppositories Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Indometacin and Furazolidone Suppositories by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Indometacin and Furazolidone Suppositories Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Indometacin and Furazolidone Suppositories Sales by Region (2021-2026) & (K Units) Table 41. Global Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Region (2021-2026) Table 42. Global Indometacin and Furazolidone Suppositories Sales by Region (2021-2026) & (US$ Million) Table 43. Global Indometacin and Furazolidone Suppositories Sales Market Share in Value by Region (2021-2026) Table 44. Global Indometacin and Furazolidone Suppositories Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Indometacin and Furazolidone Suppositories Sales by Region (2027-2032) & (K Units) Table 46. Global Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Region (2027-2032) Table 47. Global Indometacin and Furazolidone Suppositories Sales by Region (2027-2032) & (US$ Million) Table 48. Global Indometacin and Furazolidone Suppositories Sales Market Share in Value by Region (2027-2032) Table 49. Global Indometacin and Furazolidone Suppositories Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Indometacin and Furazolidone Suppositories Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Indometacin and Furazolidone Suppositories Sales by Application (2021-2026) & (K Units) Table 52. Global Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Application (2021-2026) Table 53. Global Indometacin and Furazolidone Suppositories Sales by Application (2021-2026) & (US$ Million) Table 54. Global Indometacin and Furazolidone Suppositories Sales Market Share in Value by Application (2021-2026) Table 55. Global Indometacin and Furazolidone Suppositories Price by Application (2021-2026) & (US$/Unit) Table 56. Global Indometacin and Furazolidone Suppositories Sales by Application (2027-2032) & (K Units) Table 57. Global Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Application (2027-2032) Table 58. Global Indometacin and Furazolidone Suppositories Sales by Application (2027-2032) & (US$ Million) Table 59. Global Indometacin and Furazolidone Suppositories Sales Market Share in Value by Application (2027-2032) Table 60. Global Indometacin and Furazolidone Suppositories Price by Application (2027-2032) & (US$/Unit) Table 61. North America Indometacin and Furazolidone Suppositories Sales by Application (2021-2026) & (K Units) Table 62. North America Indometacin and Furazolidone Suppositories Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Indometacin and Furazolidone Suppositories Sales by Application (2021-2026) & (K Units) Table 64. Europe Indometacin and Furazolidone Suppositories Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Indometacin and Furazolidone Suppositories Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Indometacin and Furazolidone Suppositories Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Indometacin and Furazolidone Suppositories Sales by Application (2021-2026) & (K Units) Table 68. Latin America Indometacin and Furazolidone Suppositories Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Indometacin and Furazolidone Suppositories Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Indometacin and Furazolidone Suppositories Sales by Application (2021-2026) & (US$ Million) Table 71. Cixiang Pharmaceutical Hubei Co., Ltd. Company Information Table 72. Cixiang Pharmaceutical Hubei Co., Ltd. Business Overview Table 73. Cixiang Pharmaceutical Hubei Co., Ltd. Indometacin and Furazolidone Suppositories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Cixiang Pharmaceutical Hubei Co., Ltd. Indometacin and Furazolidone Suppositories Product Portfolio Table 75. Cixiang Pharmaceutical Hubei Co., Ltd. Recent Development Table 76. Harbin Tianmei Pharmaceutical Co., Ltd. Company Information Table 77. Harbin Tianmei Pharmaceutical Co., Ltd. Business Overview Table 78. Harbin Tianmei Pharmaceutical Co., Ltd. Indometacin and Furazolidone Suppositories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Harbin Tianmei Pharmaceutical Co., Ltd. Indometacin and Furazolidone Suppositories Product Portfolio Table 80. Harbin Tianmei Pharmaceutical Co., Ltd. Recent Development Table 81. Heilongjiang Fudong Pharmaceutical Co., Ltd. Company Information Table 82. Heilongjiang Fudong Pharmaceutical Co., Ltd. Business Overview Table 83. Heilongjiang Fudong Pharmaceutical Co., Ltd. Indometacin and Furazolidone Suppositories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Heilongjiang Fudong Pharmaceutical Co., Ltd. Indometacin and Furazolidone Suppositories Product Portfolio Table 85. Heilongjiang Fudong Pharmaceutical Co., Ltd. Recent Development Table 86. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Company Information Table 87. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Business Overview Table 88. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Indometacin and Furazolidone Suppositories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Indometacin and Furazolidone Suppositories Product Portfolio Table 90. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Recent Development Table 91. North America Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America Indometacin and Furazolidone Suppositories Sales by Country (2021-2026) & (K Units) Table 93. North America Indometacin and Furazolidone Suppositories Sales Market Share by Country (2021-2026) Table 94. North America Indometacin and Furazolidone Suppositories Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America Indometacin and Furazolidone Suppositories Sales Market Share Forecast by Country (2027-2032) Table 96. North America Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Indometacin and Furazolidone Suppositories Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Indometacin and Furazolidone Suppositories Market Share by Country (2021-2026) Table 99. North America Indometacin and Furazolidone Suppositories Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Indometacin and Furazolidone Suppositories Market Share Forecast by Country (2027-2032) Table 101. Europe Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe Indometacin and Furazolidone Suppositories Sales by Country (2021-2026) & (K Units) Table 103. Europe Indometacin and Furazolidone Suppositories Sales Market Share by Country (2021-2026) Table 104. Europe Indometacin and Furazolidone Suppositories Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe Indometacin and Furazolidone Suppositories Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Indometacin and Furazolidone Suppositories Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Indometacin and Furazolidone Suppositories Market Share by Country (2021-2026) Table 109. Europe Indometacin and Furazolidone Suppositories Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Indometacin and Furazolidone Suppositories Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Indometacin and Furazolidone Suppositories Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific Indometacin and Furazolidone Suppositories Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Indometacin and Furazolidone Suppositories Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific Indometacin and Furazolidone Suppositories Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Indometacin and Furazolidone Suppositories Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Indometacin and Furazolidone Suppositories Market Share by Country (2021-2026) Table 119. Asia-Pacific Indometacin and Furazolidone Suppositories Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Indometacin and Furazolidone Suppositories Market Share Forecast by Country (2027-2032) Table 121. Latin America Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America Indometacin and Furazolidone Suppositories Sales by Country (2021-2026) & (K Units) Table 123. Latin America Indometacin and Furazolidone Suppositories Sales Market Share by Country (2021-2026) Table 124. Latin America Indometacin and Furazolidone Suppositories Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America Indometacin and Furazolidone Suppositories Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Indometacin and Furazolidone Suppositories Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Indometacin and Furazolidone Suppositories Market Share by Country (2021-2026) Table 129. Latin America Indometacin and Furazolidone Suppositories Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Indometacin and Furazolidone Suppositories Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Indometacin and Furazolidone Suppositories Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa Indometacin and Furazolidone Suppositories Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Indometacin and Furazolidone Suppositories Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Indometacin and Furazolidone Suppositories Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Indometacin and Furazolidone Suppositories Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Indometacin and Furazolidone Suppositories Market Share by Country (2021-2026) Table 139. Middle East and Africa Indometacin and Furazolidone Suppositories Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Indometacin and Furazolidone Suppositories Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Indometacin and Furazolidone Suppositories Distributors List Table 144. Indometacin and Furazolidone Suppositories Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Indometacin and Furazolidone Suppositories Image Figure 2. Global Indometacin and Furazolidone Suppositories Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Indometacin and Furazolidone Suppositories Market Size (2021-2032) & (US$ Million) Figure 4. Global Indometacin and Furazolidone Suppositories Sales (2021-2032) & (K Units) Figure 5. Indomethacin 75mg, Furazolidone 0.1g, Erythritol 5mg Image Figure 6. Global Indomethacin 75mg, Furazolidone 0.1g, Erythritol 5mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. Indomethacin 75mg, Furazolidone 0.1g, Borneol 10mg Image Figure 8. Global Indomethacin 75mg, Furazolidone 0.1g, Borneol 10mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Indometacin and Furazolidone Suppositories Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Indometacin and Furazolidone Suppositories Market Share by Type 2025 VS 2032 Figure 11. North America Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Type in 2025 Figure 12. North America Indometacin and Furazolidone Suppositories Sales Market Share in Value by Type in 2025 Figure 13. Europe Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Type in 2025 Figure 14. Europe Indometacin and Furazolidone Suppositories Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Indometacin and Furazolidone Suppositories Sales Market Share in Value by Type in 2025 Figure 17. Latin America Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Indometacin and Furazolidone Suppositories Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Indometacin and Furazolidone Suppositories Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Indometacin and Furazolidone Suppositories Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Indometacin and Furazolidone Suppositories Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Indometacin and Furazolidone Suppositories Market Share by Application 2025 VS 2032 Figure 31. North America Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Application in 2025 Figure 32. North America Indometacin and Furazolidone Suppositories Sales Market Share in Value by Application in 2025 Figure 33. Europe Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Application in 2025 Figure 34. Europe Indometacin and Furazolidone Suppositories Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Indometacin and Furazolidone Suppositories Sales Market Share in Value by Application in 2025 Figure 37. Latin America Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Indometacin and Furazolidone Suppositories Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Indometacin and Furazolidone Suppositories Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Indometacin and Furazolidone Suppositories Sales Market Share in Value by Application in 2025 Figure 41. North America Indometacin and Furazolidone Suppositories Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Indometacin and Furazolidone Suppositories Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Indometacin and Furazolidone Suppositories Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Indometacin and Furazolidone Suppositories Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Indometacin and Furazolidone Suppositories Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Indometacin and Furazolidone Suppositories Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Indometacin and Furazolidone Suppositories Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Indometacin and Furazolidone Suppositories Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Indometacin and Furazolidone Suppositories Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Indometacin and Furazolidone Suppositories Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Indometacin and Furazolidone Suppositories Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Indometacin and Furazolidone Suppositories Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Indometacin and Furazolidone Suppositories Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Indometacin and Furazolidone Suppositories Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Indometacin and Furazolidone Suppositories Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Indometacin and Furazolidone Suppositories Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Indometacin and Furazolidone Suppositories Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Indometacin and Furazolidone Suppositories Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Indometacin and Furazolidone Suppositories Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Indometacin and Furazolidone Suppositories Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Indometacin and Furazolidone Suppositories Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Indometacin and Furazolidone Suppositories Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Indomethacin 75mg, Furazolidone 0.1g, Erythritol 5mg
  • Indomethacin 75mg, Furazolidone 0.1g, Borneol 10mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Cixiang Pharmaceutical Hubei Co., Ltd.
  • Harbin Tianmei Pharmaceutical Co., Ltd.
  • Heilongjiang Fudong Pharmaceutical Co., Ltd.
  • Shanxi Qianyuan Pharmaceutical Group Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Indometacin and Furazolidone Suppositories Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Indometacin and Furazolidone Suppositories Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Indometacin and Furazolidone Suppositories Market by Type
  6. 1.3.1 Indomethacin 75mg, Furazolidone 0.1g, Erythritol 5mg
  7. 1.3.2 Indomethacin 75mg, Furazolidone 0.1g, Borneol 10mg
  8. 1.4 Global Indometacin and Furazolidone Suppositories Market Size by Type
  9. 1.4.1 Global Indometacin and Furazolidone Suppositories Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Indometacin and Furazolidone Suppositories Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Indometacin and Furazolidone Suppositories Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Indometacin and Furazolidone Suppositories Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Indometacin and Furazolidone Suppositories Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Indometacin and Furazolidone Suppositories Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Indometacin and Furazolidone Suppositories Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Indometacin and Furazolidone Suppositories Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Indometacin and Furazolidone Suppositories Industry Trends
  2. 2.2 Indometacin and Furazolidone Suppositories Industry Drivers
  3. 2.3 Indometacin and Furazolidone Suppositories Industry Opportunities and Challenges
  4. 2.4 Indometacin and Furazolidone Suppositories Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Indometacin and Furazolidone Suppositories Revenue (2021-2026)
  2. 3.2 Global Top Players by Indometacin and Furazolidone Suppositories Sales (2021-2026)
  3. 3.3 Global Top Players by Indometacin and Furazolidone Suppositories Price (2021-2026)
  4. 3.4 Global Indometacin and Furazolidone Suppositories Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Indometacin and Furazolidone Suppositories Major Company Production Sites & Headquarters
  6. 3.6 Global Indometacin and Furazolidone Suppositories Company, Product Type & Application
  7. 3.7 Global Indometacin and Furazolidone Suppositories Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Indometacin and Furazolidone Suppositories Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Indometacin and Furazolidone Suppositories Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Indometacin and Furazolidone Suppositories Tier 1, Tier 2, and Tier 3
4 Indometacin and Furazolidone Suppositories Regional Status and Outlook
  1. 4.1 Global Indometacin and Furazolidone Suppositories Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Indometacin and Furazolidone Suppositories Historic Market Size by Region
  3. 4.2.1 Global Indometacin and Furazolidone Suppositories Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Indometacin and Furazolidone Suppositories Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Indometacin and Furazolidone Suppositories Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Indometacin and Furazolidone Suppositories Forecasted Market Size by Region
  7. 4.3.1 Global Indometacin and Furazolidone Suppositories Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Indometacin and Furazolidone Suppositories Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Indometacin and Furazolidone Suppositories Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Indometacin and Furazolidone Suppositories by Application
  1. 5.1 Indometacin and Furazolidone Suppositories Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Indometacin and Furazolidone Suppositories Market Size by Application
  6. 5.2.1 Global Indometacin and Furazolidone Suppositories Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Indometacin and Furazolidone Suppositories Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Indometacin and Furazolidone Suppositories Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Indometacin and Furazolidone Suppositories Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Indometacin and Furazolidone Suppositories Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Indometacin and Furazolidone Suppositories Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Indometacin and Furazolidone Suppositories Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Indometacin and Furazolidone Suppositories Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cixiang Pharmaceutical Hubei Co., Ltd.
  2. 6.1.1 Cixiang Pharmaceutical Hubei Co., Ltd. Company Information
  3. 6.1.2 Cixiang Pharmaceutical Hubei Co., Ltd. Business Overview
  4. 6.1.3 Cixiang Pharmaceutical Hubei Co., Ltd. Indometacin and Furazolidone Suppositories Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cixiang Pharmaceutical Hubei Co., Ltd. Indometacin and Furazolidone Suppositories Product Portfolio
  6. 6.1.5 Cixiang Pharmaceutical Hubei Co., Ltd. Recent Developments
  7. 6.2 Harbin Tianmei Pharmaceutical Co., Ltd.
  8. 6.2.1 Harbin Tianmei Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Harbin Tianmei Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Harbin Tianmei Pharmaceutical Co., Ltd. Indometacin and Furazolidone Suppositories Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Harbin Tianmei Pharmaceutical Co., Ltd. Indometacin and Furazolidone Suppositories Product Portfolio
  12. 6.2.5 Harbin Tianmei Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Heilongjiang Fudong Pharmaceutical Co., Ltd.
  14. 6.3.1 Heilongjiang Fudong Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Heilongjiang Fudong Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Heilongjiang Fudong Pharmaceutical Co., Ltd. Indometacin and Furazolidone Suppositories Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Heilongjiang Fudong Pharmaceutical Co., Ltd. Indometacin and Furazolidone Suppositories Product Portfolio
  18. 6.3.5 Heilongjiang Fudong Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
  20. 6.4.1 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Company Information
  21. 6.4.2 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Business Overview
  22. 6.4.3 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Indometacin and Furazolidone Suppositories Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Indometacin and Furazolidone Suppositories Product Portfolio
  24. 6.4.5 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Indometacin and Furazolidone Suppositories Sales by Country
  2. 7.1.1 North America Indometacin and Furazolidone Suppositories Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Indometacin and Furazolidone Suppositories Sales by Country (2021-2026)
  4. 7.1.3 North America Indometacin and Furazolidone Suppositories Sales Forecast by Country (2027-2032)
  5. 7.2 North America Indometacin and Furazolidone Suppositories Market Size by Country
  6. 7.2.1 North America Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Indometacin and Furazolidone Suppositories Market Size by Country (2021-2026)
  8. 7.2.3 North America Indometacin and Furazolidone Suppositories Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Indometacin and Furazolidone Suppositories Sales by Country
  2. 8.1.1 Europe Indometacin and Furazolidone Suppositories Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Indometacin and Furazolidone Suppositories Sales by Country (2021-2026)
  4. 8.1.3 Europe Indometacin and Furazolidone Suppositories Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Indometacin and Furazolidone Suppositories Market Size by Country
  6. 8.2.1 Europe Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Indometacin and Furazolidone Suppositories Market Size by Country (2021-2026)
  8. 8.2.3 Europe Indometacin and Furazolidone Suppositories Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Indometacin and Furazolidone Suppositories Sales by Country
  2. 9.1.1 Asia-Pacific Indometacin and Furazolidone Suppositories Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Indometacin and Furazolidone Suppositories Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Indometacin and Furazolidone Suppositories Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Indometacin and Furazolidone Suppositories Market Size by Country
  6. 9.2.1 Asia-Pacific Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Indometacin and Furazolidone Suppositories Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Indometacin and Furazolidone Suppositories Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Indometacin and Furazolidone Suppositories Sales by Country
  2. 10.1.1 South America Indometacin and Furazolidone Suppositories Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Indometacin and Furazolidone Suppositories Sales by Country (2021-2026)
  4. 10.1.3 South America Indometacin and Furazolidone Suppositories Sales Forecast by Country (2027-2032)
  5. 10.2 South America Indometacin and Furazolidone Suppositories Market Size by Country
  6. 10.2.1 South America Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Indometacin and Furazolidone Suppositories Market Size by Country (2021-2026)
  8. 10.2.3 South America Indometacin and Furazolidone Suppositories Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Indometacin and Furazolidone Suppositories Sales by Country
  2. 11.1.1 Middle East and Africa Indometacin and Furazolidone Suppositories Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Indometacin and Furazolidone Suppositories Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Indometacin and Furazolidone Suppositories Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Indometacin and Furazolidone Suppositories Market Size by Country
  6. 11.2.1 Middle East and Africa Indometacin and Furazolidone Suppositories Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Indometacin and Furazolidone Suppositories Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Indometacin and Furazolidone Suppositories Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Indometacin and Furazolidone Suppositories Value Chain Analysis
  2. 12.1.1 Indometacin and Furazolidone Suppositories Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Indometacin and Furazolidone Suppositories Production Mode & Process
  7. 12.2 Indometacin and Furazolidone Suppositories Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Indometacin and Furazolidone Suppositories Distributors
  10. 12.2.3 Indometacin and Furazolidone Suppositories Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst